Nidan Laboratories and Healthcare Ltd. has announced a board meeting on 28th May 2025 approving the audited financial results for the year ended 31st March 2025. Revenue from operations rose slightly to Rs 24.53 Cr versus Rs 24.18 Cr last year. Profit before tax improved to Rs 2.76 Cr from a loss of Rs 2.37 Cr previously. The company invested Rs 20 Cr in a group company during the year. Operating cash flows remain positive at Rs 2.28 Cr, despite a net cash outflow of Rs 0.95 Cr in cash and equivalents. Debt levels decreased marginally overall.
All announcements from Nidan Laboratories and Healthcare Limited